US FDA ‘Closer To Zero’ Meeting On Infant Nutrition Safety And Benefits Set For November
Executive Summary
CFSAN launched “C2Z” initiative in April following widespread reports of contamination of baby food products. Agency officials will outline C2Z plan including a four-stage approach for continual improvement and additional work related to levels of toxic elements in food.
You may also be interested in...
Abbott Recalls Infant Formula Made At Facility FDA Is Investigating For Bacterial Contamination
Abbott Labs recalls Similac, Alimentum and EleCare brand formula powders made at Sturgis, MI, plant. FDA says complaints about Abbott’s formulas included three reports of Cronobacter sakazakii infections, with one death potentially linked, and one of Salmonella Newport infection.
Formulas For Success: Abbott Touts Similarity To Breast Milk, ByHeart Promotes ‘Clean Label’
Infant nutrition giant Abbott extends its Similac line with its “closest formula to breast milk ever” while startup ByHeart approaches its initial launch with announcement its formula is first certified by Clean Label Project.
Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request
FDA’s justification report published with Biden administration’s FY2022 federal budget request includes $1.194bn for agency’s food programs, which include its oversight of supplement industry, up from $1.11bn in FY2021 appropriation.